Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPermnt Tsb 30 Regulatory News (73HR)

Share Price Information for Permnt Tsb 30 (73HR)

Share Price is delayed by 15 minutes
Get Live Data
0.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: -
73HR Live PriceLast checked at - London Stock Exchange

Intraday Permnt Tsb 30 Share Chart

Trading Statement

24 Oct 2014 17:15

RNS Number : 2969V
Permanent TSB Group Holdings PLC
24 October 2014
 



 

 

 

permanent tsb Group Holdings plc (ptsbgh or "the Group") - Trading Update

Group reports good progress across key objectives in year-to-date.

 

· Continued progress towards overall profitability of Group with NIM rising steadily

· Mortgage lending up strongly

· Net impairment provision release in Q3, 2014 (pre-HPI adjustment)

· Accelerated deleveraging through redemptions and asset sales

· Steady deposit growth at reducing rates

17:15 Friday 24th October 2014. Following this week's announcement that it is has agreed the sale of Springboard Mortgages Ltd and associated loans, and in advance of the announcement of the results of the Single Supervisory Mechanism Comprehensive Assessment (CA), the Group issues this Trading Update.

Commenting on the Group's current performance, Group Chief Executive Jeremy Masding said: "This trading update contains further good news on impairment provisions and confirms the progress we are making towards delivering sustainable profitability and achieving key deleveraging goals. In short, the Group has made good progress on its continuing journey towards full profitability."

 

  

Key Points:

 Product Performance:

· New mortgage approvals to end September - up 123% year-on-year, with drawdowns up 212% year-on-year

· Market share for new mortgages now estimated at over 13% (from low of 1.6% in Q4, 2012)

· New personal term lending has increased 17% year on year

· Continued success with current accounts - 88,000 current accounts opened since the new launch initiated in 2013

· Total deposits have increased over 9% on end 2013 levels and over 3% on H1 2014. In line with trends in previous periods, both the cost of deposits, and the overall cost of funds has continued to reduce

 

Profitability:

As described below impairment continues to reduce significantly.

In line with the trend in previous periods, the gradual expansion of Net Interest Margin and Net Interest Income is continuing despite reductions in the yield on Tracker mortgages, arising from reduced ECB rates. The overall improvement in NII is enabled by the continuing trend in both the reduction of the cost of funds and reduction in ELG fees as covered liabilities continue to mature.

 

Operating expenses are expected to reduce from the elevated levels in H1 2014 which was affected by significant non-recurring items. However, this will be partially offset by costs associated with new business initiatives and increasing costs of regulation.

 

 

Arrears and Impairment:

Underlying arrears levels continue to be managed down in each of the loan portfolios within the Group's Asset Management Unit. Over 90 days arrears levels are down 24.7% from peak and 23.1% year to date.

We achieved our MART targets for Q3 2014 and the level of engagement from our customer base remains high.

As a result, we expect the provisions for impairment charge in the second half to be significantly reduced from the levels in H1 2014, which were in turn 65% lower than H1 2013. Notwithstanding that the Group has maintained a conservative peak to trough fall assumption of 55% for Irish Residential Property prices, the Group saw a net provision release in the third quarter.

In future periods this positive trend is anticipated to continue, driven also by improving macroeconomic indicators, particularly the improvement in the residential property prices and reducing levels of unemployment.

 

Funding and Liquidity:

ECB borrowings are now more than two thirds lower than their peak level in 2011 and reduced by over a quarter from the level at the end of 2013. This has been enabled by, from end 2013:

· Deposit growth of €1.7bn;

· €0.9bn reductions in debt securities held;

· €0.7bn reductions in NAMA bonds; and

· Ongoing reduction in total loan book levels.

With that, the Loans-to-Deposits Ratio for the Group has continued to reduce and at c135% is 16ppt reduced from end 2013 and 6ppt reduced from H1 2014.

The Group expects to be fully compliant with incoming Liquidity Coverage Ratio requirements under Basel 3, as implemented under the Capital Requirements Directive IV (CRDIV).

 

Deleveraging:

In line with the Group's stated policy of deleveraging non-core assets, it has completed significant deleveraging in the current year, with gross loans on a constant currency basis down €1.2bn, 3.6% since 31 December 2013. In addition to providing additional liquidity, these sales also created a net improvement to the Group's regulatory capital position:

· September 2014: Sale of a portfolio of €235m of Residential Mortgage Backed Securities.

· September 2014: Disposal of a €222m (Stg£172m) tranche of UK based loans. In addition CHL has had repayments and redemptions of Stg£204 million for the year to the end of September 2014.

· October 2014: Agreement on sale of the subsidiary Springboard Mortgages Ltd, a wholly owned subsidiary of the Group, which focussed on non-conforming mortgages in the Irish market. The par value of the loan book was €468 million, with over 70% of these loans being non-performing (4% of the Group non-performing loans at 30 June 2014).

As a result, the sale of all of the assets classified as held for sale at 30 June 2014 have now been completed.

 

Further preparatory work has been undertaken in relation to the CRE portfolios and we expect that a tranche/tranches of this portfolio will be brought to market in the near future.

 

  

SSM Comprehensive Assessment:

The Group will announce its response to the results of the SSM Comprehensive Assessment by press release on Sunday 26th October.

 

 

 

Contact Details

Glen Lucken, Group Chief Financial Officer

Tel: +353 1 669 5145

 

 

Media:

Ray Gordon

Gordon MRM

ptsb@gordonmrm.ie

Mobile +353 87 2417373

 

Note on forward-looking information:

 

This Announcement contains forward-looking statements, which are subject to risks and uncertainties because they relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends, and similar expressions concerning matters that are not historical facts. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of the Company or the industry in which it operates, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements referred to in this paragraph speak only as at the date of this Announcement. The Company will not undertake any obligation to release publicly any revision or updates to these forward-looking statements to reflect future events, circumstances, unanticipated events, new information or otherwise except as required by law or by any appropriate regulatory authority.

 

ends

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGMMZGVDMGDZM
Date   Source Headline
1st Mar 20237:00 amRNSCommentary on 2022 Annual Financial Report
1st Mar 20237:00 amRNSAnnual Financial Report
17th Jan 202310:00 amRNSAppointment of Board Chairperson Designate
11th Nov 20227:00 amRNSTrading Statement
7th Nov 20227:30 amRNSUlster Bank Retail Business: Acquisition Completed
21st Sep 20224:00 pmRNSSale of Buy To Let Portfolio
4th Aug 202210:00 amRNSDirectorate Change
27th Jul 20227:00 amRNSHalf-year Report
27th Jul 20227:00 amRNSCommentary on 2022 Half-Year Report
22nd Jul 20228:01 amRNSCompetition clearance received on Ulster Bank deal
24th Jun 202212:40 pmRNSResult of EGM
24th Jun 202212:40 pmRNSResult of AGM
3rd May 20227:00 amRNSTrading Statement
31st Mar 20229:30 amRNSDirectorate Change
2nd Mar 20227:00 amRNSCommentary on 2021 Annual Financial Report
26th Jan 202212:00 pmRNSSuccession Plan for Board Chairman
17th Dec 20217:15 amRNSAcquisition of elements of Ulster Bank business
10th Nov 202110:00 amRNSSale of Loan Portfolio
28th Oct 20217:00 amRNSTrading Statement
28th Jul 20217:00 amRNSHalf-year Report
28th Jul 20217:00 amRNSCommentary on 2021 Half-Year Report
23rd Jul 20217:00 amRNSPotential acquisition: Certain Ulster Bank Assets
5th May 20217:00 amRNSTrading Statement
3rd Mar 20217:00 amRNSAnnual Financial Report
3rd Mar 20217:00 amRNSCommentary on 2020 Annual Financial Report
24th Feb 20217:00 amRNSRedemption of AT1 Securities
19th Feb 20217:05 amRNSStatement re: Ulster Bank Withdrawal from ROI
3rd Nov 20207:00 amRNSTrading Statement
27th Oct 20207:00 amRNSSale of Buy To Let Loan Portfolio
25th Sep 202010:00 amRNSAppointment of Interim CFO
4th Aug 20207:00 amRNSCommentary on Half-Year Report
4th Aug 20207:00 amRNSHalf-year Report
22nd Jun 202010:00 amRNSAppointment of Chief Executive Officer
14th May 20207:00 amRNSTrading Statement
26th Feb 20207:00 amRNSAnnual Financial Report
26th Feb 20207:00 amRNSCommentary on Annual Financial Report
6th Nov 20197:00 amRNSTrading Statement
29th Oct 20193:00 pmRNSDirectorate Change
24th Oct 20192:00 pmRNSChief Executive To Step Down During 2020
3rd Oct 201910:49 amBUSEarly Redemption(s)
12th Sep 20192:00 pmRNSSale of Non-Performing Loan Portfolio
26th Jul 20195:00 pmRNSHalf-year Report
25th Jul 20197:00 amRNS2019 Half Year Report Commentary
30th May 20192:00 pmRNSConclusion of Tracker Enforcement Investigation
27th Mar 20196:30 pmRNSAnnual Financial Report
29th Nov 20184:00 pmRNSSecuritisation of a Non-Performing Loan Portfolio
8th Nov 20187:00 amRNSTrading Statement
3rd Oct 201811:00 amRNSDirectorate Change
30th Aug 20188:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.